Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ANET vs GSK✓SelectedUSD · GSKANET vs GSK performance historyLatest closeAs of-11.59%11/20
Stock and ETF performance explorer

ANET vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+19.3%
GSK return
-4.9%
Excess return
+24.2%
Maximum drawdown
-26.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-11.6%-0.1%-11.5%-11.7%
7D-15.0%-5.3%-9.7%-17.7%
30D-9.1%-3.7%-5.4%-11.0%
3M-8.8%-7.3%-1.5%-12.9%
6M+19.3%-4.2%+23.6%+19.4%
All+19.3%-4.9%+24.2%+19.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling